Robert M. Jones, Ph.D, FRSC
Affiliations: | 2018- | Condor Therapeutics |
Area:
etrasimod, olorinab, Small Molecules, GPCRsGoogle:
"Robert Jones"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Peter J. Garratt | grad student | 1992-1995 | UCL |
| Philip S. Portoghese | post-doc | 1996-1998 | UMN |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hassing HA, Fares S, Larsen O, et al. (2016) Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119. Biochemical Pharmacology |
| Han S, Thatte J, Buzard DJ, et al. (2013) Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. Journal of Medicinal Chemistry. 56: 8224-56 |
| Buzard DJ, Lehmann J, Han S, et al. (2012) GPR119 agonists 2009-2011. Pharmaceutical Patent Analyst. 1: 285-99 |
| Buzard D, Han S, Thoresen L, et al. (2011) Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1Pâ‚ agonists. Bioorganic & Medicinal Chemistry Letters. 21: 6013-8 |
| Semple G, Fioravanti B, Pereira G, et al. (2008) Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. Journal of Medicinal Chemistry. 51: 5172-5 |
| Waldhoer M, Fong J, Jones RM, et al. (2005) A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proceedings of the National Academy of Sciences of the United States of America. 102: 9050-5 |
| Mague SD, Pliakas AM, Todtenkopf MS, et al. (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. The Journal of Pharmacology and Experimental Therapeutics. 305: 323-30 |
| Negus SS, Mello NK, Linsenmayer DC, et al. (2002) Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Psychopharmacology. 163: 412-9 |
| Jewett DC, Grace MK, Jones RM, et al. (2001) The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats. Brain Research. 909: 75-80 |
| Sharma SK, Jones RM, Metzger TG, et al. (2001) Transformation of a kappa-opioid receptor antagonist to a kappa-agonist by transfer of a guanidinium group from the 5'- to 6'-position of naltrindole. Journal of Medicinal Chemistry. 44: 2073-9 |